Where Europe's Smart Money Is Quietly Flowing in 2026

Jan de Vries · 2026-10-12

Investment ambitions across the EU for AI and HealthTech are vast, and the money is starting to follow the rhetoric. The EU's InvestAI initiative aims to mobilize €200 billion (about $217 billion) for artificial intelligence, including serious funding for large-scale AI infrastructure. That's not the only push. The European Commission and the European Investment Bank Group have also launched BioTechEU, designed to mobilize €10 billion (roughly $10.9 billion) for biotech and life sciences across 2026 and 2027. And it's not just public money moving. Wealthy private investors are leaning in too. The UBS Global Family Office Report 2026 found that 65% of family offices were already invested in AI, with 33% allocated to AI-enabled healthcare. So why is so much private capital heading toward AI and HealthTech? Let's break it down. ### The EU Is Building the Pipes, Not Just Talking About Them The scale of Europe's investment and infrastructure plans tells you how strategically important AI has become. Infrastructure is the clearest signal. In July 2026, the EU requested up to seven AI Gigafactories, backed by up to €10 billion in EU and national funding and expected to unlock at least €20 billion (around $21.7 billion) in additional private investment across the Union. Life sciences are also a heavyweight part of the EU economy, already contributing nearly €1.5 trillion in value and supporting 29 million jobs. BioTechEU is meant to push that further, and the European Commission's wider life sciences strategy includes measures to make multi-country clinical trials easier to fund. There's also €300 million (about $326 million) set aside to stimulate procurement of life sciences innovations, including next-generation vaccines and affordable cancer solutions. As investment moves into these high-growth sectors, investors can also explore private-market opportunities through firms operating across venture capital, private equity and real estate markets. ### Why AI and HealthTech Are Growing So Fast The EU has a massive life sciences industry, major research institutions, sprawling healthcare systems, and rapidly expanding AI infrastructure. That combination explains a lot of the investor interest. By April 2026, 19 AI Factories had been deployed across European supercomputers, supported by 13 regional AI Factory antennas. That gives researchers, startups and businesses far greater access to AI computing capacity. EU and participating EuroHPC countries have committed more than €2.6 billion (roughly $2.8 billion) to the AI Factories and Antennas initiative. Then there's the healthcare side. The European Health Data Space is designed to make health data easier to access and reuse securely across the EU for research, innovation and regulatory purposes. That creates potentially valuable infrastructure for medical research and AI development. Other EU projects include building specialist datasets: - Cancer Image Europe, expected to provide access to 60 million cancer images by the end of 2026 - The 1+ Million Genomes initiative, which aims to provide secure access to genomic and associated clinical data The EU is also trying to move AI from research into clinical settings. In 2026, the European Commission made €9 million (about $9.8 million) available for two large-scale pilots of AI-powered medical imaging, covering X-rays, CT scans, MRI, PET and ultrasound. For investors, the attraction is that HealthTech is moving beyond laboratory research into real-world clinical testing and EU-backed deployment programs. ### The Quiet Capital Rotation It's hard to track exactly what every high-net-worth individual is investing in. Much private investment simply isn't publicly disclosed. But the direction is clear: family offices are telling us where their attention is going, and the numbers back it up. > "The smart money isn't chasing hype. It's following the infrastructure, the data, and the regulatory tailwinds that make these sectors investable for the long haul." That's the pattern worth watching in 2026. Europe is putting real money behind AI and HealthTech, and private investors are quietly positioning themselves alongside it.